NYSE - Delayed Quote • USD
UnitedHealth Group Incorporated (UNH)
At close: 4:00 PM EDT
After hours: 6:04 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 22 | 22 | 26 | 27 |
| Avg. Estimate | 6.75 | 7.23 | 27.6 | 31.14 |
| Low Estimate | 5.86 | 6.52 | 25.46 | 29.74 |
| High Estimate | 7.17 | 7.43 | 28.18 | 31.85 |
| Year Ago EPS | 6.14 | 6.56 | 23.15 | 27.6 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 16 | 16 | 22 | 22 |
| Avg. Estimate | 98.98B | 99.1B | 399.1B | 429.08B |
| Low Estimate | 97.26B | 97.82B | 393.54B | 416.63B |
| High Estimate | 100.75B | 100.32B | 402.69B | 436.73B |
| Year Ago Sales | -- | -- | 342.52B | 399.1B |
| Sales Growth (year/est) | -- | -- | 16.50% | 7.50% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | 5.99 | 6.32 | 5.51 | 6.61 |
| EPS Actual | 6.14 | 6.56 | 5.68 | 6.91 |
| Difference | 0.15 | 0.24 | 0.17 | 0.3 |
| Surprise % | 2.50% | 3.80% | 3.10% | 4.50% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 6.75 | 7.23 | 27.6 | 31.14 |
| 7 Days Ago | 6.83 | 7.2 | 27.52 | 31.11 |
| 30 Days Ago | 6.91 | 7.38 | 27.77 | 31.34 |
| 60 Days Ago | 6.91 | 7.31 | 27.8 | 31.35 |
| 90 Days Ago | 6.91 | 7.34 | 27.79 | 31.3 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 3 | 7 | 5 | 5 |
| Up Last 30 Days | 4 | 7 | 6 | 6 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 12 | 10 | 5 | 5 |
Growth Estimates
| CURRENCY IN USD | UNH | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 9.90% | -- | -- | 1.60% |
| Next Qtr. | 10.20% | -- | -- | 10.50% |
| Current Year | 19.20% | -- | -- | 5.20% |
| Next Year | 12.80% | -- | -- | 13.30% |
| Next 5 Years (per annum) | 12.92% | -- | -- | 11.22% |
| Past 5 Years (per annum) | 13.76% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Maintains | Deutsche Bank: Buy to Buy | 4/19/2024 |
| Reiterates | Truist Securities: Buy to Buy | 4/17/2024 |
| Maintains | RBC Capital: Outperform to Outperform | 4/17/2024 |
| Maintains | Barclays: Overweight to Overweight | 4/17/2024 |
| Maintains | Piper Sandler: Overweight to Overweight | 4/17/2024 |
| Maintains | TD Cowen: Buy to Buy | 4/10/2024 |
Related Tickers
HUM Humana Inc.
328.33
+1.08%
CVS CVS Health Corporation
69.75
+1.49%
ELV Elevance Health, Inc.
531.42
+1.19%
CI The Cigna Group
352.39
+1.04%
CNC Centene Corporation
75.15
+1.90%
MOH Molina Healthcare, Inc.
367.52
+1.82%
OSCR Oscar Health, Inc.
16.01
-2.67%
CLOV Clover Health Investments, Corp.
0.6356
+0.71%
NEUE NeueHealth, Inc.
5.82
-7.77%
ALHC Alignment Healthcare, Inc.
5.20
+1.96%